Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Humana Inc’s stock clocked out at $251.11, down -5.22% from its previous closing price of $264.94. In other words, the price has decreased by -$5.22 from its previous closing price. On the day, 2.45 million shares were traded. HUM stock price reached its highest trading level at $264.405 during the session, while it also had its lowest trading level at $250.99.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Sell rating and assigned the stock a target price of $235.
On September 22, 2025, Evercore ISI started tracking the stock assigning a In-line rating and target price of $295.
Raymond James Upgraded its Mkt Perform to Outperform on May 01, 2025, while the target price for the stock was maintained at $315.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when Rechtin James A. bought 6,530 shares for $229.25 per share. The transaction valued at 1,496,984 led to the insider holds 30,474 shares of the business.
Diamond Susan M bought 10,959 shares of HUM for $2,732,134 on Apr 08 ’25. On Feb 24 ’25, another insider, Huval Timothy S., who serves as the Former Chief Administrative Of of the company, bought 1,247 shares for $258.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 30201772032 and an Enterprise Value of 21052770304. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.52, and their Forward P/E ratio for the next fiscal year is 19.21. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.18. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24 while its Price-to-Book (P/B) ratio in mrq is 1.63. Its current Enterprise Value per Revenue stands at 0.167 whereas that against EBITDA is 5.752.
Stock Price History:
The Beta on a monthly basis for HUM is 0.46, which has changed by -0.08045256 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $315.35, while it has fallen to a 52-week low of $206.87. The 50-Day Moving Average of the stock is -9.98%, while the 200-Day Moving Average is calculated to be -4.35%.
Shares Statistics:
It appears that HUM traded 1.81M shares on average per day over the past three months and 1513450 shares per day over the past ten days. A total of 120.27M shares are outstanding, with a floating share count of 119.99M. Insiders hold about 0.23% of the company’s shares, while institutions hold 101.09% stake in the company. Shares short for HUM as of 1760486400 were 3972444 with a Short Ratio of 2.20, compared to 1757894400 on 4078437. Therefore, it implies a Short% of Shares Outstanding of 3972444 and a Short% of Float of 3.7100002.
Dividends & Splits
With its trailing 12-month dividend rate of 0.885, HUM has a forward annual dividend rate of 3.54. Against a Trailing Annual Dividend Yield of 0.0033403789. The stock’s 5-year Average Dividend Yield is 0.85. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-09-26 with an ex-dividend date of 2025-12-26. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
Earnings Estimates
Investors are keenly observing as 23.0 analysts analyze and rate. The current performance of Humana Inc (HUM) in the stock market.The consensus estimate for the next quarter is $10.88, with high estimates of $12.35 and low estimates of $8.66.
Analysts are recommending an EPS of between $17.25 and $16.57 for the fiscal current year, implying an average EPS of $17.02. EPS for the following year is $13.18, with 25.0 analysts recommending between $15.85 and $10.52.
Revenue Estimates
In. The current quarter, 17 analysts expect revenue to total $31.98B. It ranges from a high estimate of $32.39B to a low estimate of $31.52B. As of. The current estimate, Humana Inc’s year-ago sales were $29.21BFor the next quarter, 17 analysts are estimating revenue of $34.71B. There is a high estimate of $39.28B for the next quarter, whereas the lowest estimate is $31.85B.
A total of 19 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $129.54B, while the lowest revenue estimate was $128.01B, resulting in an average revenue estimate of $128.87B. In the same quarter a year ago, actual revenue was $117.76BBased on 19 analysts’ estimates, the company’s revenue will be $139.23B in the next fiscal year. The high estimate is $159.34B and the low estimate is $121.6B.
